H.M. Fishbon Memorial Library
Recent Mount Zion Authors
Updated March 2008
Bauer
J, Bastian BC.
[DNA copy number changes in the
diagnosis of melanocytic tumors]
Pathologe. 2007 Nov;28(6):464-73. German.
PMID: 17882420 [PubMed - indexed
for MEDLINE]
Benanti
JA, Cheung SK, Brady MC, Toczyski DP.
A proteomic screen reveals SCFGrr1
targets that regulate the glycolytic-gluconeogenic switch.
Nat Cell Biol. 2007
Oct;9(10):1184-91. Epub 2007 Sep 9.
PMID: 17828247 [PubMed -
indexed for MEDLINE]
Bidlingmaier
S, Liu B.
Interrogating yeast surface-displayed
human proteome to identify small molecule-binding proteins.
Mol Cell
Proteomics. 2007 Nov;6(11):2012-20. Epub 2007 Jul 28.
PMID: 17660511 [PubMed - indexed for
MEDLINE]
Campbell
MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar
AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz
CC.
Breast cancer growth prevention by
statins.
Cancer Res.
2006 Sep 1;66(17):8707-14.
PMID: 16951186 [PubMed - indexed for
MEDLINE]
Chan
JK, Ueda SM, Sugiyama VE, Stave CD, Shin JY, Monk BJ, Sikic BI, Osann K,
Kapp DS.
Analysis of Phase II Studies on
Targeted Agents and Subsequent Phase III Trials: What Are the Predictors
for Success?
J
Clin Oncol. 2008 Feb 19; [Epub ahead of print]
PMID: 18285603
[PubMed - as supplied by publisher]
Chan
JK, Kapp DS, Cheung MK, Shin JY, Stieglitz D, Husain A, Teng NN, Berek JS,
Osann K, Guo H.
Prognostic factors and risk of
extrauterine metastases in 3867 women with grade 1 endometrioid corpus
cancer.
Am J Obstet
Gynecol. 2008 Feb;198(2):216.e1-5.
PMID:
18226629 [PubMed - indexed for MEDLINE]
Chan
JK, Kapp DS, Shin JY, Osann K, Leiserowitz GS, Cress RD, O'Malley
C.
Factors associated with the suboptimal
treatment of women less than 55 years of age with early-stage ovarian
cancer.
Gynecol
Oncol. 2008 Jan;108(1):95-9. Epub 2007 Oct 18.
PMID: 17949796 [PubMed - indexed for
MEDLINE]
Chan
JK, Hamilton CA, Anderson EM, Cheung MK, Baker J, Husain A, Teng NN, Kong
CS, Negrin RS.
A novel technique for the enrichment
of primary ovarian cancer cells.
Am J Obstet
Gynecol. 2007 Nov;197(5):507.e1-5.
PMID:
17980191 [PubMed - indexed for MEDLINE]
Chen
AM, Daly ME, El-Sayed I, Garcia J, Lee NY, Bucci MK, Kaplan
MJ.
Patterns of failure after
combined-modality approaches incorporating radiotherapy for sinonasal
undifferentiated carcinoma of the head and neck.
Int
J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):338-43.
PMID: 18207030 [PubMed - in
process]
April 22, 2008
Radiation therapy for cutaneous
squamous cell carcinoma involving the parotid area lymph nodes: dose and
volume considerations.
Int
J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1377-80. Epub 2007 Aug 8.
PMID: 17689882 [PubMed -
indexed for MEDLINE]
Chiaverotti
T, Couto SS, Donjacour A, Mao JH, Nagase H, Cardiff RD, Cunha GR, Balmain
A.
Dissociation of epithelial and
neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of
mouse prostate model of prostate cancer.
Am J Pathol. 2008
Jan;172(1):236-46. Epub 2007 Dec 21.
PMID: 18156212 [PubMed -
in process]
Climent
J, Garcia JL, Mao JH, Arsuaga J, Perez-Losada J.
Characterization of breast cancer by
array comparative genomic hybridization.
Biochem
Cell Biol. 2007 Aug;85(4):497-508. Review.
PMID:
17713584 [PubMed - indexed for MEDLINE]
Clément
G, Guilleret I, He B, Yagui-Beltrán A, Lin YC, You L, Xu Z, Shi Y, Okamoto
J, Benhattar J, Jablons D.
Epigenetic alteration of the Wnt
inhibitory factor-1 promoter occurs early in the carcinogenesis of
Barrett's esophagus.
Cancer
Sci. 2008 Jan;99(1):46-53. Epub 2007 Nov 13.
PMID: 18005197 [PubMed - indexed for
MEDLINE]
Dall'era
MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA,
Holmberg L, Bailey DE Jr, Wallace ME, Kantoff PW, Carroll
PR.
Active surveillance for early-stage
prostate cancer: review of the current literature.
Cancer. 2008 Feb 27; [Epub ahead of print]
PMID:
18306379 [PubMed - as supplied by publisher]
Dall'era
MA, Konety BR.
Active surveillance for low-risk
prostate cancer: selection of patients and predictors of
progression.
Nat Clin Pract Urol. 2008
Feb 19; [Epub ahead of print]
PMID: 18285752 [PubMed - as supplied by
publisher]
Davies
BJ, Walsh TJ, Ross PL, Knight SJ, Sadetsky N, Carroll PR, Kane
CJ.
Effect of BMI on Primary Treatment of
Prostate Cancer.
Urology. 2008
Feb 9; [Epub ahead of print]
PMID: 18267336 [PubMed - as supplied by
publisher]
Denardo
DG, Johansson M, Coussens LM.
Immune cells as mediators of solid
tumor metastasis.
Cancer Metastasis Rev. 2008
Mar;27(1):11-8.
PMID: 18066650 [PubMed - in
process]
El-Sayed
I, Huang X, Macheret F, Humstoe JO, Kramer R, El-Sayed M.
Effect of plasmonic gold nanoparticles
on benign and malignant cellular autofluorescence: a novel probe for
fluorescence based detection of cancer.
Technol Cancer Res
Treat. 2007 Oct;6(5):403-12.
PMID: 17877428
[PubMed - indexed for MEDLINE]
Estep
AL, Palmer C, McCormick F, Rauen KA.
Mutation Analysis of BRAF, MEK1 and
MEK2 in 15 Ovarian Cancer Cell Lines: Implications for Therapy.
PLoS ONE. 2007 Dec 5;2(12):e1279.
PMID: 18060073 [PubMed - in
process]
Faddegon
BA, Perl J, Asai M.
Monte Carlo simulation of large
electron fields.
Phys Med Biol. 2008 Mar
7;53(5):1497-510. Epub 2008 Feb 21.
PMID: 18296775 [PubMed
- in process]
Fejerman
L, Ziv E.
Population differences in breast
cancer severity.
Pharmacogenomics. 2008 Mar;9(3):323-333.
PMID: 18303968 [PubMed - as supplied by
publisher]
Gajduskova
P, Snijders AM, Kwek S, Roydasgupta R, Fridlyand J, Tokuyasu T, Pinkel D,
Albertson DG.
Genome position and gene
amplification.
Genome
Biol. 2007;8(6):R120.
PMID: 17584934
[PubMed - indexed for MEDLINE]
Harzstark
AL, Ryan CJ.
Therapies in development for
castrate-resistant prostate cancer.
Expert Rev Anticancer
Ther. 2008 Feb;8(2):259-68.
PMID: 18279066
[PubMed - in process]
Harzstark
AL, Ryan CJ.
Novel therapeutic strategies in
development for prostate cancer.
Expert Opin Investig
Drugs. 2008 Jan;17(1):13-22. Review.
PMID:
18095915 [PubMed - indexed for MEDLINE]
Hittelman
A, Sridharan S, Roy R, Fridlyand J, Loda M, Collins C, Paris
PL.
Evaluation of whole genome
amplification protocols for array and oligonucleotide CGH.
Diagn
Mol Pathol. 2007 Dec;16(4):198-206.
PMID: 18043282
[PubMed - indexed for MEDLINE]
Hsieh
AC, Ryan CJ.
Novel concepts in androgen receptor
blockade.
Cancer J. 2008
Jan-Feb;14(1):11-4.
PMID: 18303477 [PubMed - in
process]
Hsieh
AC, Small EJ, Ryan CJ.
Androgen-response elements in
hormone-refractory prostate cancer: implications for treatment
development.
Lancet
Oncol. 2007 Oct;8(10):933-9. Review.
PMID:
17913662 [PubMed - indexed for MEDLINE]
Hwang
ES, Miglioretti DL, Ballard-Barbash R, Weaver DL, Kerlikowske K; National
Cancer Institute Breast Cancer Surveillance Consortium.
Association between breast density and
subsequent breast cancer following treatment for ductal carcinoma in
situ.
Cancer
Epidemiol Biomarkers Prev. 2007 Dec;16(12):2587-93.
PMID: 18086762 [PubMed - indexed for
MEDLINE]
Iacovides
DC, O'Shea CC, Oses-Prieto J, Burlingame A, McCormick F.
Critical role for arginine methylation
in adenovirus-infected cells.
J Virol. 2007 Dec;81(23):13209-17. Epub 2007 Aug 8.
PMID: 17686851 [PubMed -
indexed for MEDLINE]
Ikeda
T, Shinohara K.
Comparison of prostate and transition
zone volume measured by the ellipsoid and planimetric methods with
transrectal ultrasonography before seed implantation of prostate
cancer.
Int
J Urol. 2008 Feb;15(2):190-1.
PMID: 18269465
[PubMed - in process]
Kebebew
E. Hereditary Non-medullary Thyroid
Cancer.
World J
Surg. 2007 Dec 7; [Epub ahead of print]
PMID: 18058169 [PubMed
- as supplied by publisher]
Kenfield
SA, Chang ST, Chan JM. Diet and lifestyle interventions in
active surveillance patients with favorable-risk prostate cancer.
Curr Treat
Options Oncol. 2007 Jun;8(3):173-96. Review.
PMID:
17763836 [PubMed - indexed for MEDLINE]
Kitagawa
M, Lee SH, McCormick F. Skp2 Suppresses p53-Dependent
Apoptosis by Inhibiting p300.
Mol Cell. 2008 Feb 1;29(2):217-31.
PMID: 18243116 [PubMed - in
process]
Ko
AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero
MA. Excess toxicity associated with
docetaxel and irinotecan in patients with metastatic,
gemcitabine-refractory pancreatic cancer: results of a phase II
study.
Cancer
Invest. 2008 Feb;26(1):47-52.
PMID: 18181045
[PubMed - indexed for MEDLINE]
Kushchayeva
Y, Duh QY, Kebebew E, D'Avanzo A, Clark OH. Comparison of clinical characteristics
at diagnosis and during follow-up in 118 patients with Hurthle cell or
follicular thyroid cancer.
Am J Surg. 2007 Dec 9; [Epub
ahead of print]
PMID: 18070728 [PubMed - as supplied by
publisher]
Lin
D, Glastonbury CM, Rafaelian O, Eisele DW, Wang SJ. Management of advanced nodal disease
following chemoradiation for head and neck squamous cell carcinoma: role
of magnetic resonance imaging.
J Otolaryngol. 2007 Dec;36(6):350-6.
PMID: 18076845 [PubMed - indexed for
MEDLINE]
Lometti
MW, Thurston D, Aubin M, Bock A, Verhey L, Lockhart JM, Bland R, Pouliot
J, Roach M 3rd. Are lateral electronic portal images
adequate for accurate on-line daily targeting of the prostate? Results of
a prospective study.
Med
Dosim. 2008 Spring;33(1):22-9.
PMID: 18262119
[PubMed - in process]
Long
BR, Ndhlovu LC, Oksenberg JR, Lanier LL, Hecht FM, Nixon DF, Barbour
JD. KIR3DS1 Conferral of Enhanced Natural
Killer Cell Function in Early HIV-1 Infection.
J Virol. 2008 Feb 27; [Epub ahead of
print]
PMID: 18305035 [PubMed - as supplied by
publisher]
Mersereau
JE, Evans ML, Moore DH, Liu JH, Thomas MA, Rebar RW, Pennington E, Cedars
MI. Luteal phase estrogen is decreased in
regularly menstruating older women compared with a reference population of
younger women.
Menopause. 2008 Jan 17; [Epub
ahead of print]
PMID: 18202592 [PubMed - as supplied by
publisher]
Michaëlsson
J, Long BR, Loo CP, Lanier LL, Spotts G, Hecht FM, Nixon DF. Immune reconstitution of CD56(dim) NK
cells in individuals with primary HIV-1 infection treated with
interleukin-2.
J Infect Dis. 2008 Jan
1;197(1):117-25.
PMID: 18171294 [PubMed - indexed for
MEDLINE]
Moasser
MM. Targeting the function of the HER2
oncogene in human cancer therapeutics.
Oncogene. 2007 Oct 11;26(46):6577-92. Epub 2007 May 7. Review.
PMID: 17486079
[PubMed - indexed for MEDLINE]
Moasser
MM. The oncogene HER2: its signaling and
transforming functions and its role in human cancer pathogenesis.
Oncogene. 2007 Oct 4;26(45):6469-87. Epub 2007 Apr 30. Review.
PMID: 17471238
[PubMed - indexed for MEDLINE]
Nápoles-Springer
AM, Livaudais JC, Bloom J, Hwang S, Kaplan CP. Information exchange and decision
making in the treatment of Latina and white women with ductal carcinoma in
situ.
J
Psychosoc Oncol. 2007;25(4):19-36.
PMID: 18032263
[PubMed - indexed for MEDLINE]
Pietras
K, Pahler J, Bergers G, Hanahan D. Functions of paracrine PDGF signaling
in the proangiogenic tumor stroma revealed by pharmacological
targeting.
PLoS Med.
2008 Jan 29;5(1):e19.
PMID: 18232728 [PubMed - in
process]
Rabow
MW, Wrubel J, Remen RN. Authentic community as an educational
strategy for advancing professionalism: a national evaluation of the
Healer's Art course.
J
Gen Intern Med. 2007 Oct;22(10):1422-8. Epub 2007 Jul 10.
PMID: 17619932 [PubMed - indexed for
MEDLINE]
Rangel
J, Nosrati M, Torabian S, Shaikh L, Leong SP, Haqq C, Miller JR 3rd,
Sagebiel RW, Kashani-Sabet M. Osteopontin as a molecular prognostic
marker for melanoma.
Cancer.
2008 Jan 1;112(1):144-50.
PMID: 18023025 [PubMed - indexed for
MEDLINE]
Roach
M 3rd, Bae K, Speight J, Wolkov HB, Rubin P, Lee RJ, Lawton C, Valicenti
R, Grignon D, Pilepich MV. Short-term neoadjuvant androgen
deprivation therapy and external-beam radiotherapy for locally advanced
prostate cancer: long-term results of RTOG 8610.
J
Clin Oncol. 2008 Feb 1;26(4):585-91. Epub 2008 Jan 2.
PMID: 18172188 [PubMed - indexed for
MEDLINE]
Roach
M 3rd. Dose escalated external beam
radiotherapy versus neoadjuvant androgen deprivation therapy and
conventional dose external beam radiotherapy for clinically localized
prostate cancer: do we need both?
Strahlenther
Onkol. 2007 Dec;183 Spec No 2:26-8. Review.
PMID: 18167004 [PubMed - indexed for
MEDLINE]
Rosenberg
JE, Halabi S, Sanford BL, Himelstein AL, Atkins JN, Hohl RJ, Millard F,
Bajorin DF, Small EJ; for the Cancer and Leukemia Group B. Phase II study of bortezomib in
patients with previously treated advanced urothelial tract transitional
cell carcinoma: CALGB 90207.
Ann
Oncol. 2008 Feb 13; [Epub ahead of print]
PMID: 18272914
[PubMed - as supplied by publisher]
Rosenberg
JE. Current status of neoadjuvant and
adjuvant chemotherapy for muscle-invasive bladder cancer.
Expert Rev
Anticancer Ther. 2007 Dec;7(12):1729-36.
PMID:
18062747 [PubMed - in process]
Rosenberg
JE, Weinberg VK, Kelly WK, Michaelson D, Hussain MH, Wilding G, Gross M,
Hutcheon D, Small EJ. Activity of second-line chemotherapy
in docetaxel-refractory hormone-refractory prostate cancer patients :
randomized phase 2 study of ixabepilone or mitoxantrone and
prednisone.
Cancer. 2007 Aug
1;110(3):556-63.
PMID: 17577218 [PubMed - indexed for
MEDLINE]
Rugo
HS. The breast cancer continuum in
hormone-receptor-positive breast cancer in postmenopausal women: evolving
management options focusing on aromatase inhibitors.
Ann
Oncol. 2008 Jan;19(1):16-27. Epub 2007 Aug 9.
Review.
PMID: 17693420 [PubMed - indexed for
MEDLINE]
Ryan
CJ, Weinberg V, Rosenberg J, Fong L, Lin A, Kim J, Small EJ. Phase II study of ketoconazole plus
granulocyte-macrophage colony-stimulating factor for prostate cancer:
effect of extent of disease on outcome.
J Urol. 2007 Dec;178(6):2372-6; discussion 2377. Epub 2007 Oct 22.
PMID:
17936834 [PubMed - indexed for MEDLINE]
Ryan
CJ, Small EJ. Prostate cancer update: 2005.
Curr Opin Oncol.
2006 May;18(3):284-8. Review.
PMID: 16552242 [PubMed - indexed for
MEDLINE]
Sadetsky
N, Lubeck DP, Pasta DJ, Latini DM, DuChane J, Carroll PR. Insurance and quality of life in men
with prostate cancer: data from the Cancer of the Prostate Strategic
Urological Research Endeavor.
BJU Int. 2008 Mar;101(6):691-7.
PMID: 18291018 [PubMed - in
process]
Shinohara
K, Roach M 3rd. Technique for implantation of fiducial
markers in the prostate.
Urology. 2008 Feb;71(2):196-200.
PMID: 18308082
[PubMed - in process]
Sippel
RS, Elaraj DM, Khanafshar E, Zarnegar R, Kebebew E, Duh QY, Clark
OH. Tumor Size Predicts Malignant
Potential in Hürthle Cell Neoplasms of the Thyroid.
World J Surg. 2008 Jan 27; [Epub
ahead of print]
PMID: 18224463 [PubMed - as supplied by
publisher]
Sippel
RS, Elaraj DM, Khanafshar E, Kebebew E, Duh QY, Clark OH. Does the presence of additional
thyroid nodules on ultrasound alter the risk of malignancy in patients
with a follicular neoplasm of the thyroid?
Surgery. 2007 Dec;142(6):851-7; discussion 857.e1-2.
Epub 2007 Oct 26. Erratum in: Surgery. 2008 Feb;143(2):302.
PMID:
18063067 [PubMed - indexed for MEDLINE]
Small
EJ, Fontana J, Tannir N, DiPaola RS, Wilding G, Rubin M, Iacona RB,
Kabbinavar FF. A phase II trial of gefitinib in
patients with non-metastatic hormone-refractory prostate cancer.
BJU Int. 2007 Oct;100(4):765-9.
PMID: 17822457 [PubMed - indexed for
MEDLINE]
Snijders
AM, Hermsen MA, Baughman J, Buffart TE, Huey B, Gajduskova P, Roydasgupta
R, Tokuyasu T, Meijer GA, Fridlyand J, Albertson DG. Acquired genomic aberrations
associated with methotrexate resistance vary with background genomic
instability.
Genes Chromosomes Cancer.
2008 Jan;47(1):71-83.
PMID: 17943968 [PubMed - indexed for
MEDLINE]
Soucek
L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for
angiogenesis and macroscopic expansion of Myc-induced pancreatic islet
tumors.
Nat Med.
2007 Oct;13(10):1211-8. Epub 2007 Sep 30.
PMID: 17906636 [PubMed -
indexed for MEDLINE]
Stier
EA, Goldstone SE, Berry JM, Panther LA, Jay N, Krown SE, Lee J, Palefsky
JM. Infrared coagulator treatment of
high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy
consortium pilot study.
J Acquir
Immune Defic Syndr. 2008 Jan 1;47(1):56-61.
PMID: 18156992
[PubMed - indexed for MEDLINE]
Sutton-Tyrrell
K, Venkitachalam L, Kanaya AM, Boudreau R, Harris T, Thompson T, Mackey
RH, Visser M, Vaidean GD, Newman AB. Relationship of ankle blood pressures
to cardiovascular events in older adults.
Stroke. 2008
Mar;39(3):863-9. Epub 2008 Feb 7.
PMID: 18258843 [PubMed - in
process]
Tlsty
TD, Coussens LM. Tumor stroma and regulation of cancer
development.
Annu Rev Pathol. 2006;1:119-50. Review.
PMID:
18039110 [PubMed - indexed for MEDLINE]
Ueda
SM, Kapp DS, Cheung MK, Shin JY, Osann K, Husain A, Teng NN, Berek JS,
Chan JK. Trends in demographic and clinical
characteristics in women diagnosed with corpus cancer and their potential
impact on the increasing number of deaths.
Am J Obstet
Gynecol. 2008 Feb;198(2):218.e1-6.
PMID:
18226630 [PubMed - indexed for MEDLINE]
Walsh
KB, Lanier LL, Lane TE. NKG2D receptor signaling enhances
cytolytic activity by virus-specific CD8+ T cells: evidence for a
protective role in virus-induced encephalitis.
J Virol. 2008 Mar;82(6):3031-44. Epub 2007 Dec 26.
PMID: 18160433 [PubMed -
in process]
Wieduwilt
MJ, Moasser MM. The epidermal growth factor receptor
family: Biology driving targeted therapeutics.
Cell Mol Life
Sci. 2008 Feb 9; [Epub ahead of print]
PMID: 18259690 [PubMed -
as supplied by publisher]
Woodruff
TJ, Carlson A, Schwartz JM, Giudice LC. Proceedings of the Summit on
Environmental Challenges to Reproductive Health and Fertility: executive
summary.
Fertil
Steril. 2008 Feb;89(2):281-300.
PMID: 18275883
[PubMed - in process]
Wulfkuhle
JD, Speer R, Pierobon M, Laird J, Espina V, Deng J, Mammano E, Yang SX,
Swain SM, Nitti D, Esserman LJ, Belluco C, Liotta LA, Petricoin EF
3rd. Multiplexed Cell Signaling Analysis of
Human Breast Cancer Applications for Personalized Therapy.
J Proteome Res.
2008 Feb 8; [Epub ahead of print] PMID: 18257519 [PubMed - as supplied
by publisher]
Zhang
S, Lovejoy KS, Shima JE, Lagpacan LL, Shu Y, Lapuk A, Chen Y, Komori T,
Gray JW, Chen X, Lippard SJ, Giacomini KM. Organic cation transporters are
determinants of oxaliplatin cytotoxicity.
Cancer Res. 2006 Sep 1;66(17):8847-57.
PMID: 16951202 [PubMed - indexed for
MEDLINE]
Resources for Patients
Patients and visitors can learn more about the resources available to them at the Fishbon Library via the HealthWorks website.